Bausch Health Companies | VRX - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Amgen USD 9.19B 532M 2026-03
ANI Pharmaceuticals USD 562.3M 21.58M 2026-03
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Bausch Health Companies USD -2.06B 1.5B 2026-03
Biogen USD 18.65B 394.9M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Canopy Growth CAD 697.59M 60.58M 2026-03
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Danaher USD 52.95B 415M 2026-03
Drreddys Laboratories INR 380.46B 376.31B 2026-03
Eli Lilly USD 31.2B 4.66B 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Novo Nordisk DKK 203.07B 9.02B 2026-03
Pacira USD 653.89M 39.22M 2026-03
Perrigo USD 2.5B 436.7M 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 1.89B 58.06M 2026-03
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03
Zoetis USD 3.23B 98M 2026-03